Bostongene

Bostongene Tumor Portrait Report How To Access It With Hensley Bostongene optimizes oncology pipelines through ai powered insights from tumor and immune biology. Accelerating drug development with integrated multimodal ai | bostongene is redefining cancer patient care and drug development through the integration of omnimodal data and ai.

Home Bostongene Bostongene combines data from genes, rna, proteins, the immune system and the tumor environment to help pharma and biotech develop targeted therapies, design efficient trials, and improve outcomes. Waltham, mass. (business wire) bostongene, a developer of the leading ai foundation model for tumor and immune biology, today announced that 13 abstracts have been selected for presentation at the american association for cancer research (aacr) annual meeting 2026, held from april 17 22, at the. Bostongene helps drug developers de risk and accelerate research and development using a clinically validated ai platform purpose built for oncology and supported by a clia certified and cap. Bostongene will present research demonstrating how its ai foundation model for tumor and immune biology enables disease level modeling by integrating multimodal data from electronic medical records, genomics, transcriptomics, imaging, and immune profiling.

Home Bostongene Bostongene helps drug developers de risk and accelerate research and development using a clinically validated ai platform purpose built for oncology and supported by a clia certified and cap. Bostongene will present research demonstrating how its ai foundation model for tumor and immune biology enables disease level modeling by integrating multimodal data from electronic medical records, genomics, transcriptomics, imaging, and immune profiling. About bostongene corporation bostongene is redefining cancer patient care and drug development through the integration of omnimodal data and artificial intelligence. Bostongene, a pioneer in precision medicine, is leveraging tabpfn in its analysis of multi modal data from genomic and immune system profiling to enhance success for drug developers and improve patient outcomes. Success storiesread our case studies to learn how bostongene tumor portrait™ tests have enabled personalized treatment options based on molecular and immune profiles. The two institutions have formed a strategic alliance to develop and validate biomarkers for cancer diagnosis and treatment. bostongene's computational platform and laboratory services will be integrated with md anderson's clinical and research expertise.